Noemí Rotllan (Noemi Rotllan)

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

International journal of molecular sciences

Biomedicines

Current atherosclerosis reports

Journal of clinical medicine

Hospital de la Santa Creu i Sant Pau Institut de Recerca

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de la Santa Creu i Sant Pau Institut de Recerca May 01 2019

Spain

Investigador Principal :: Metabolic Bases of Cardiovascular Risk Group

Yale University May 01 2014 - Jan 31 2019

United States

Associate Research Scientist :: Comparative Medicine

New York University May 01 2010 - Aug 31 2013

United States

Postdoctoral fellowship :: Cardiovascular

Publications

Noemí Rotllan, Joan Carles Escolà-Gil
Apolipoproteins and Lipoproteins in Health and Disease 2.0. International journal of molecular sciences 25 (11) (2024)
Noemí Rotllan, Joan Carles Escolà-Gil
Apolipoproteins and Lipoproteins in Health and Disease 2.0. International journal of molecular sciences 25 (11) (2024)
Marina Canyelles, Carla Borràs, Noemí Rotllan, Mireia Tondo, Joan Carles Escolà-Gil, Francisco Blanco-Vaca
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? International journal of molecular sciences 24 (3) (2023)
Marina Canyelles, Carla Borràs, Noemí Rotllan, Mireia Tondo, Joan Carles Escolà-Gil, Francisco Blanco-Vaca
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? International journal of molecular sciences 24 (3) (2023)
Núria Puig, Arnau Solé, Ana Aguilera-Simón, Raquel Griñán, Noemí Rotllan, Pol Camps-Renom, Sonia Benitez
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. International journal of molecular sciences 24 (18) (2023)
Marina Canyelles, Carla Borràs, Noemí Rotllan, Mireia Tondo, Joan Carles Escolà-Gil, Francisco Blanco-Vaca
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? International journal of molecular sciences 24 (3) (2023)
Núria Puig, Jose Rives, Montserrat Estruch, Ana Aguilera-Simón, Noemí Rotllan, Mercedes Camacho, Núria Colomé, Francesc Canals, José Luis Sanchez-Quesada, Sonia Benitez
Presence of Ceramidase Activity in Electronegative LDL. International journal of molecular sciences 24 (1) (2022)
Noemí Rotllan
The Underlying Pathology of Atherosclerosis: Different Players. International journal of molecular sciences 23 (6) (2022)
Núria Puig, Jose Rives, Montserrat Estruch, Ana Aguilera-Simón, Noemí Rotllan, Mercedes Camacho, Núria Colomé, Francesc Canals, José Luis Sanchez-Quesada, Sonia Benitez
Presence of Ceramidase Activity in Electronegative LDL. International journal of molecular sciences 24 (1) (2022)
Raquel Griñán, Joan Carles Escolà-Gil, Josep Julve, Sonia Benitez, Noemí Rotllan
Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis. International journal of molecular sciences 23 (20) (2022)
Núria Puig, Jose Rives, Montserrat Estruch, Ana Aguilera-Simón, Noemí Rotllan, Mercedes Camacho, Núria Colomé, Francesc Canals, José Luis Sanchez-Quesada, Sonia Benitez
Presence of Ceramidase Activity in Electronegative LDL. International journal of molecular sciences 24 (1) (2022)
Marina Canyelles, Melania Plaza, Noemí Rotllan, Dolors Llobet, Josep Julve, Sergi Mojal, Maribel Diaz-Ricart, José Manuel Soria, Joan Carles Escolà-Gil, Mireia Tondo, Francisco Blanco-Vaca, Joan Carles Souto
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism. Journal of clinical medicine 11 (5) (2022)
Ane San Jose-Urteaga, Kepa B Uribe, Martín César, Francisco Blanco-Vaca, Noemí Rotllan
(r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management? Biomaterials science 9 (9) (2021)
Noemí Rotllan, Mercedes Camacho, Mireia Tondo, Elena M G Diarte-Añazco, Marina Canyelles, Karen Alejandra Méndez-Lara, Sonia Benitez, Núria Alonso, Esmeralda Castelblanco, Joan Carles Escolà-Gil, Francisco Blanco-Vaca, Josep Julve
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases. Antioxidants (Basel, Switzerland) 10 (12) (2021)
Marina Canyelles, Álvaro García-Osuna, Alexandra Junza, Óscar Yanes, Núria Puig, Jordi Ordóñez-Llanos, Alessandro Sionis, Jordi Sans-Roselló, Aitor Alquezar Arbé, David Santos, Noemí Rotllan, Josep Julve, Mireia Tondo, Joan Carles Escolà-Gil, Francisco Blanco-Vaca
The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux-But Not Gut Microbial-Derived Metabolites-Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction. Biomedicines 9 (10) (2021)
Joan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, Francisco Blanco-Vaca
Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia. Current atherosclerosis reports 23 (6) (2021)
Kepa B Uribe, Ane San Jose-Urteaga, Noemí Rotllan, Cristina M Ramírez, Shifa Jebari-Benslaiman, Leigh Goedeke, Alberto Canfrán-Duque, Unai Galicia-García, Diego Saenz De Urturi, Patricia Aspichueta, Yajaira Suárez, Carlos Fernández-Hernando, Martín César
miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression. International journal of molecular sciences 21 (22) (2020)
Ashish Misra, Zhonghui Feng, Rachana R Chandran, Inamul Kabir, Noemí Rotllan, Binod Aryal, Abdul Q Sheikh, Ling Ding, Lingfeng Qin, Carlos Fernández-Hernando, George Tellides, Daniel M Greif
Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells. Nature communications 9 (1) (2018)

Noemí Rotllan.css-eqlu8i{font-size:small;padding-left:4px;} (Noemi Rotllan)

Publication Activity (10 Years)

Top Topics

Top Venues

Noemí Rotllan (Noemi Rotllan)